Salts of an epidermal growth factor receptor kinase inhibitor
US10005738B2 · kind B2 · utility
3Cited by
66References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2017 |
| Grant date | Jun 26, 2018 |
| Priority date | — |
| Expiry date | Jan 9, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.